Erin N Schoenfelder1, Stephen V Faraone2, Scott H Kollins3. 1. Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, North Carolina; and ESchoenfelder@gmail.com. 2. Departments of Psychiatry and of Neuroscience and Physiology, State University of New York Upstate Medical University, Syracuse, New York. 3. Department of Psychiatry and Behavioral Sciences, School of Medicine, Duke University, Durham, North Carolina; and.
Abstract
BACKGROUND AND OBJECTIVE: Individuals with attention-deficit/hyperactivity disorder (ADHD) have a significantly higher risk of cigarette smoking. The nature of the relationship between smoking and psychostimulant medications commonly used to treat ADHD is controversial. Our objective was to examine the relationship between stimulant treatment of ADHD and cigarette smoking by using meta-analysis, and to identify study and sample characteristics that moderate this relationship. METHODS: Literature searches on PubMed and PsycInfo databases identified published studies for inclusion. Included studies compared cigarette smoking outcomes for stimulant-treated and untreated ADHD individuals. Seventeen studies met inclusion criteria, and 14 (total n = 2360) contained sufficient statistical information for inclusion in the meta-analysis. Two authors extracted odds ratios or frequencies of smokers in the treatment or nontreatment groups, and coded study characteristics including sample source, percentage of male participants, follow-up length, treatment consistency, type of smoking measure, prospective study, and controlling for comorbidities. RESULTS: Meta-analysis revealed a significant association between stimulant treatment and lower smoking rates. Meta-regression indicated that effect sizes were larger for studies that used clinical samples, included more women, measured smoking in adolescence rather than adulthood, conceptualized stimulant treatment as consistent over time, and accounted for comorbid conduct disorder. CONCLUSIONS: Nearly all studies were naturalistic, precluding causal inferences. Available data were insufficient to examine additional influences of patient demographics, treatment effectiveness, or other comorbidities. Consistent stimulant treatment of ADHD may reduce smoking risk; the effect was larger in samples with more severe psychopathology. Implications for further research, treatment of ADHD, and smoking prevention are discussed.
BACKGROUND AND OBJECTIVE: Individuals with attention-deficit/hyperactivity disorder (ADHD) have a significantly higher risk of cigarette smoking. The nature of the relationship between smoking and psychostimulant medications commonly used to treat ADHD is controversial. Our objective was to examine the relationship between stimulant treatment of ADHD and cigarette smoking by using meta-analysis, and to identify study and sample characteristics that moderate this relationship. METHODS: Literature searches on PubMed and PsycInfo databases identified published studies for inclusion. Included studies compared cigarette smoking outcomes for stimulant-treated and untreated ADHD individuals. Seventeen studies met inclusion criteria, and 14 (total n = 2360) contained sufficient statistical information for inclusion in the meta-analysis. Two authors extracted odds ratios or frequencies of smokers in the treatment or nontreatment groups, and coded study characteristics including sample source, percentage of male participants, follow-up length, treatment consistency, type of smoking measure, prospective study, and controlling for comorbidities. RESULTS: Meta-analysis revealed a significant association between stimulant treatment and lower smoking rates. Meta-regression indicated that effect sizes were larger for studies that used clinical samples, included more women, measured smoking in adolescence rather than adulthood, conceptualized stimulant treatment as consistent over time, and accounted for comorbid conduct disorder. CONCLUSIONS: Nearly all studies were naturalistic, precluding causal inferences. Available data were insufficient to examine additional influences of patient demographics, treatment effectiveness, or other comorbidities. Consistent stimulant treatment of ADHD may reduce smoking risk; the effect was larger in samples with more severe psychopathology. Implications for further research, treatment of ADHD, and smoking prevention are discussed.
Authors: Timothy E Wilens; Laura M Gault; Ann Childress; Christopher J Kratochvil; Lindsey Bensman; Coleen M Hall; Evelyn Olson; Weining Z Robieson; Tushar S Garimella; Walid M Abi-Saab; George Apostol; Mario D Saltarelli Journal: J Am Acad Child Adolesc Psychiatry Date: 2010-11-25 Impact factor: 8.829
Authors: Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane Journal: Exp Clin Psychopharmacol Date: 2013-10 Impact factor: 3.157
Authors: Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-02-08 Impact factor: 8.829
Authors: Timothy E Wilens; Marleen H Verlinden; Lenard A Adler; Patricia J Wozniak; Scott A West Journal: Biol Psychiatry Date: 2006-02-23 Impact factor: 13.382
Authors: Jessica D Rhodes; William E Pelham; Elizabeth M Gnagy; Saul Shiffman; Karen J Derefinko; Brooke S G Molina Journal: Psychol Addict Behav Date: 2016-08
Authors: Irene J Elkins; Gretchen R B Saunders; Stephen M Malone; Margaret A Keyes; Diana R Samek; Matt McGue; William G Iacono Journal: Am J Psychiatry Date: 2017-08-25 Impact factor: 18.112
Authors: John T Mitchell; Andrea L Howard; Katherine A Belendiuk; Traci M Kennedy; Annamarie Stehli; James M Swanson; Lily Hechtman; L Eugene Arnold; Betsy Hoza; Benedetto Vitiello; Bo Lu; Scott H Kollins; Brooke S G Molina Journal: Nicotine Tob Res Date: 2019-04-17 Impact factor: 4.244
Authors: Stephen V Faraone; Tobias Banaschewski; David Coghill; Yi Zheng; Joseph Biederman; Mark A Bellgrove; Jeffrey H Newcorn; Martin Gignac; Nouf M Al Saud; Iris Manor; Luis Augusto Rohde; Li Yang; Samuele Cortese; Doron Almagor; Mark A Stein; Turki H Albatti; Haya F Aljoudi; Mohammed M J Alqahtani; Philip Asherson; Lukoye Atwoli; Sven Bölte; Jan K Buitelaar; Cleo L Crunelle; David Daley; Søren Dalsgaard; Manfred Döpfner; Stacey Espinet; Michael Fitzgerald; Barbara Franke; Manfred Gerlach; Jan Haavik; Catharina A Hartman; Cynthia M Hartung; Stephen P Hinshaw; Pieter J Hoekstra; Chris Hollis; Scott H Kollins; J J Sandra Kooij; Jonna Kuntsi; Henrik Larsson; Tingyu Li; Jing Liu; Eugene Merzon; Gregory Mattingly; Paulo Mattos; Suzanne McCarthy; Amori Yee Mikami; Brooke S G Molina; Joel T Nigg; Diane Purper-Ouakil; Olayinka O Omigbodun; Guilherme V Polanczyk; Yehuda Pollak; Alison S Poulton; Ravi Philip Rajkumar; Andrew Reding; Andreas Reif; Katya Rubia; Julia Rucklidge; Marcel Romanos; J Antoni Ramos-Quiroga; Arnt Schellekens; Anouk Scheres; Renata Schoeman; Julie B Schweitzer; Henal Shah; Mary V Solanto; Edmund Sonuga-Barke; César Soutullo; Hans-Christoph Steinhausen; James M Swanson; Anita Thapar; Gail Tripp; Geurt van de Glind; Wim van den Brink; Saskia Van der Oord; Andre Venter; Benedetto Vitiello; Susanne Walitza; Yufeng Wang Journal: Neurosci Biobehav Rev Date: 2021-02-04 Impact factor: 9.052
Authors: Arvid Skutle; Eli Torild Hellandsjø Bu; Finn Konow Jellestad; Katelijne van Emmerik-van Oortmerssen; Geert Dom; Sofie Verspreet; Pieter Jan Carpentier; Josep Antoni Ramos-Quiroga; Johan Franck; Maija Konstenius; Sharlene Kaye; Zsolt Demetrovics; Csaba Barta; Melina Fatséas; Marc Auriacombe; Brian Johnson; Stephen V Faraone; Frances R Levin; Steve Allsop; Susan Carruthers; Robert A Schoevers; Maarten W J Koeter; Wim van den Brink; Franz Moggi; Merete Møller; Geurt van de Glind Journal: Addict Behav Rep Date: 2015-03-28
Authors: Annabeth P Groenman; Lizanne J S Schweren; Wouter Weeda; Marjolein Luman; Siri D S Noordermeer; Dirk J Heslenfeld; Barbara Franke; Stephen V Faraone; Nanda Rommelse; Catharina A Hartman; Pieter J Hoekstra; Jan Buitelaar; Jaap Oosterlaan Journal: Eur Child Adolesc Psychiatry Date: 2019-02-05 Impact factor: 4.785